Nutrition & metabolism · Washington D.C., DC
Nutrition and metabolism studies in Washington D.C., DC
6 recruiting studies have a site in Washington D.C..
6 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- Washington D.C., DC + 131 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Akero Therapeutics, Inc
- Location
- Washington D.C., DC + 130 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
CorMedix Therapeutics
- Location
- Washington D.C., DC + 16 other US sites
- Eligibility basics
- Ages 12+
- RecruitingHealthy volunteers
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
National Heart, Lung, and Blood Institute (NHLBI)
- Location
- Washington D.C., DC + 1 other US site
- Eligibility basics
- Ages 1–100
- RecruitingHealthy volunteers
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
Physicians Committee for Responsible Medicine
- Location
- Washington D.C., DC
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Diabetes Reversal Online Program and Study (DROP Study)
Physicians Committee for Responsible Medicine
- Location
- Washington D.C., DC
- Eligibility basics
- Ages 18+
Who these studies look for
Expect limits on supplements, alcohol and diet changes during the study, and sometimes a set BMI range.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.